IRIS
PIZZIGALLO, Eligio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.804
AS - Asia 4.892
EU - Europa 4.817
SA - Sud America 875
Continente sconosciuto - Info sul continente non disponibili 240
AF - Africa 73
OC - Oceania 6
Totale 17.707
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.661
SG - Singapore 1.759
CN - Cina 1.447
UA - Ucraina 948
BR - Brasile 693
IE - Irlanda 690
GB - Regno Unito 648
TR - Turchia 613
RU - Federazione Russa 569
VN - Vietnam 492
FR - Francia 428
SE - Svezia 419
IT - Italia 410
DE - Germania 368
FI - Finlandia 197
IN - India 196
BD - Bangladesh 114
AR - Argentina 79
CA - Canada 73
HK - Hong Kong 45
ID - Indonesia 41
MX - Messico 28
IQ - Iraq 27
CO - Colombia 24
EC - Ecuador 24
PL - Polonia 24
ZA - Sudafrica 24
ES - Italia 22
KR - Corea 22
AT - Austria 21
CZ - Repubblica Ceca 20
JP - Giappone 16
PK - Pakistan 16
CL - Cile 15
UZ - Uzbekistan 13
VE - Venezuela 13
BE - Belgio 12
JM - Giamaica 12
PY - Paraguay 12
NL - Olanda 11
SA - Arabia Saudita 11
TN - Tunisia 11
EU - Europa 10
IL - Israele 9
MA - Marocco 9
MY - Malesia 9
TT - Trinidad e Tobago 9
JO - Giordania 8
LT - Lituania 8
PE - Perù 8
EG - Egitto 7
CR - Costa Rica 6
GR - Grecia 6
IR - Iran 6
KE - Kenya 6
NP - Nepal 6
PH - Filippine 6
AU - Australia 5
AZ - Azerbaigian 5
CH - Svizzera 5
ET - Etiopia 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
HN - Honduras 4
TH - Thailandia 4
BB - Barbados 3
GE - Georgia 3
KZ - Kazakistan 3
LB - Libano 3
OM - Oman 3
SC - Seychelles 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
GT - Guatemala 2
KW - Kuwait 2
NG - Nigeria 2
PS - Palestinian Territory 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AL - Albania 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
GD - Grenada 1
HU - Ungheria 1
KH - Cambogia 1
LK - Sri Lanka 1
LY - Libia 1
MM - Myanmar 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
Totale 17.477
Salva come PNG Salva come JPEG
Città #
Singapore 1.292
Jacksonville 1.034
San Jose 790
Dublin 688
Chandler 580
Southend 557
Princeton 351
Izmir 340
Dallas 324
Nanjing 321
Ashburn 319
Council Bluffs 307
Beijing 271
Wilmington 191
Cambridge 171
Santa Clara 168
Ho Chi Minh City 165
Los Angeles 144
Tongling 143
The Dalles 132
Nanchang 119
Dearborn 115
Hanoi 111
Buffalo 106
Moscow 102
Altamura 99
Ann Arbor 76
São Paulo 66
Boardman 63
Kunming 58
Munich 58
Woodbridge 58
Shenyang 54
Grevenbroich 52
New York 52
Tianjin 42
Hebei 41
Columbus 36
Hong Kong 36
Jiaxing 35
Toronto 32
Milan 28
Pune 28
Norwalk 27
Changsha 26
Hangzhou 25
Haiphong 24
Houston 24
Chieti 23
Brooklyn 21
Lanzhou 21
Augusta 20
Chicago 20
Da Nang 20
Rome 20
Seoul 20
Phoenix 19
Brno 18
Rio de Janeiro 18
San Mateo 18
Denver 17
Orem 17
Hefei 16
Helsinki 16
Tokyo 16
London 15
Atlanta 14
Redondo Beach 14
Belo Horizonte 13
Biên Hòa 13
Tashkent 13
Warsaw 13
Andover 12
Curitiba 12
Jinan 12
Johannesburg 12
Nuremberg 12
San Francisco 12
Turku 12
Vienna 12
Brussels 11
Changchun 11
Manchester 11
Recife 11
Stockholm 11
Boston 10
Brasília 10
Chennai 10
Fortaleza 10
Mexico City 10
Montreal 10
Mumbai 10
Salvador 10
Campinas 9
Charlotte 9
Dhaka 9
Orange 9
Quito 9
Radomsko 9
Seattle 9
Totale 10.590
Salva come PNG Salva come JPEG
Nome #
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 189
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 182
Caso clinico di endoplastite da Staphylococcus capitis. 180
HPV e displasie della cervice uterina: ricerca dell'HPV-DNA con PCR e correlazioni con l'esame citologico, colposcopico e istobioptico 164
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 162
La sindrome di Waterhouse-Friderichsen quale complicanza fatale nel bambino febbrile: descrizione di due casi clinici. 161
Acute urinary retention due to HSV-1: a case report 161
Metabolic modifications in HIV-infected women 154
Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha 152
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 151
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy 150
Alterations in muscles of CFS patients at morphological. biochemical and molecular level. 148
Autoimmunità nelle epatiti croniche in terapia con IFN-alfa 141
Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy. 141
Efficacia clinica del trattamento intravescicale con BCG per neoplasie vescicali superficiali in rapporto alla risposta immunitaria indotta. 140
Ricerca con PCR e genotipizzazione dell'HPVDNA in donne con dispiasia della cervice uterina e nei loro partner 140
Could S-100b be a marker of the neurologic involvement in HIV-affected patients? 139
Valutazione della sindrome da fatica cronica mediante A.B.R.: risultati preliminari 138
Cystatin C, adipokines and cardiovascular risk in HIV infected patients. 137
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 137
Insights the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients 136
Ricerche sull'autoimmunità in alcune epatopatie. 134
Chronic fatigue syndrome: circadian rhythm and hypothalamic-pituitary-adrenal (HPA) axis impairment. 133
Economic evaluation on HIV treatments: The I.Co.N.A. cohort study. 132
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 132
Quality of life, depression and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. 128
Clinical and Pathogenetical Characterization of 238 Patients of a Chronic Fatigue Syndrome Italian Center 127
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 126
I potenziali evocati uditivi troncoencefalici nella valutazione della Sindrome da Fatica Cronica. 126
Psychiatric diagnosis and comorbidity and chronic fatigue syndrome 125
Is moderate HIV-viremia associated with a higher risk of clinical progression in HIV-infected people treated with high active antiretroviral therapy. 125
Interruption of highly active antiretroviral therpy in HIV clinical practice. 125
Acquired immunodeficiency without HIV infection: epidemiology and clinical autcome in Italy. 123
Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. 123
Viral interference between hepatitis B, C and D viruses in dual and triple infections in HIV-positive patients. 123
Effetti del trattamento con vitamina e sulla sintomatologia muscoloscheletrica soggettiva ed oggettiva della sindrome da fatica cronica 123
A leukemic patient with hepatosplenic abscesses due to coagulase-negative staphylococci. 122
Inguinal lymphadenopathy due to Bartonella henselae 122
Ricerca degli anticorpi fissanti il complemento contro il virus dell'herpes simplex (ed altri virus neurotropi) in pazienti con sclerosi multipla. 122
Nuovi aspetti della terapia antibiotica associata (rassegna critica e contributo personale). 122
Usefulness of Leifson staining method in diagnosis of Helicobacter pylori infection. 122
Neurite acistica bilaterale HIV-correlata: descrizione di un caso ad evoluzione favorevole in seguito a terapia antiretrovirale. 121
Hepatitis C virus infection and myositis: a virus localization study. 121
Vertical transmission of hepatitis C virus: an epidemiological study on 2,980 pregnant women in Italy. 121
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. 119
Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. 119
The association of chronic hepatitis B and myopathy 118
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors. 118
Short communication: Proangiogenic hematopoietic cells in acute HIV infection 118
High dose of erythropoietin in management of interferon/ribavirin induced anemia 117
L'immunità cellulare nelle epatopatie: stimolazione in vitro dei linfociti con antigeni epatici. 116
Epatite virale B e polimiosite. Descrizione di un caso di polimiosite associato ad epatite virale B. 116
Proteinuria in an African HIV-infected patient: effects of telmisartan. 115
Peripheral blood mononuclear cell beta-endorphin concentration is decreased in chronic fatigue syndrome and fibromyalgia but not in depression: preliminary report 115
Circadian variations of prolactine (PRL), thyreotropic hormone (TSH), adrenocorticotropic hormone (ACTH) and cortisol (CS) in the chronic fatigue syndrome (CFS). 114
Methicillin-resistant staphylococcus epidermidis (MRSE) endocarditis treated with linezolid 113
MR imaging in the clinical diagnosis of chronic fatigue syndrome (CFS). 113
Ocular manifestations in chronic fatigue syndrome. 113
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 112
Sensory characterization of somatic parietal tissues in humans with chronic fatigue syndrome 112
b-endorphin concentrations are decreased in peripheral blood mononuclear cells of chronic fatigue syndrome patients: comparison with depression. 112
Predictability of sustained virological response to pegylate interferon alpha-2b plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C infection. 111
An unusual complication of brucellosis: hepatic abscess. 110
Multicentre study on the prevalence of symptoms and symptomatic treatment in HIV infection. 110
Mortality from HIV and TB coinfections in higher in Eastern Europe than in Western Europe and Argentina. 108
Ulteriori osservazioni sul sistema HBeAg-HBeAb in corso di epatite ed in portatori di HBsAg. 108
Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. 106
Granulomatous cheilitis in an HIV positive patient on HAART Therapy. 106
Valutazione comparativa delle tecniche di immunodiffusione su agar e counter-elettroforesi nella ricerca dell'antigene Australia. 106
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. 106
Patient-reported and Physician-estimated Adherence to HAART. 105
Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. 104
The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora. 103
Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing. 103
Attualità sulle infezioni batteriche del SNC. 102
Psychophysical distress and alexithymic traits in chronic fatigue syndrome with and without comorbid depression 102
Le associazioni di antibiotici: aspetti clinici. 102
Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis. 100
Antiretroviral therapy in HIV-infected individuals in clinical practice: are the criteria for initiating and choosing the type of drug regimen based only on immunologic and virologic values? 100
Study of immune alterations in patients with Chronic Fatigue Syndrome to reach a better nosografic and pathogenetic characterization of subgroups with different etiologies. 99
Chronic fatigue syndrome following a toxic exposure. 99
Risk of developing specific AIDS-defining illness in patients coinfected with HIV and hepatitis C virus with or without cirrhosis. 99
Research on a new hepatitis B antigen-antibody system: e- anti-e. 98
An Italian study on health-related quality of life and fatigue in patients with chronic fatigue syndrome and patients with chronic HCV virus infection: similarities and differences 97
Ricerca dell'anticorpo contro il virus A (=HAAb) per l'epidemiologia e la diagnosi dell'epatite A. 96
Inflammatory cytokines and S-100b protein in patients with hepatitis C infection and cryoglobulinemias 95
A case report of a new inflammatory eye syndrome in an HIV positive patient: the immune restoration uveitis. 95
Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome 93
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. 92
Relationship between HAART adherence and adipose tissue alterations. 92
Significato clinico dell'antigene “e” e dell'anticorpo anti “e” determinati con il metodo radioimmunologico. 91
Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. 91
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes 90
Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment out come in Italian chronically HCV-infected patients. 90
Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures. 90
Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART. 90
Comparative analysis of two systems for HCV genotyping. 89
Chromatographic and electrophoretic studies of immune complexes in non-A, non-B hepatitis. 89
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 89
Clinical and Pathophysiological Aspects of Chronic Fatigue Syndrome 89
Totale 11.886
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.103
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022587 0 0 5 103 47 12 11 68 52 13 85 191
2022/20231.921 206 271 112 187 178 404 136 112 226 18 27 44
2023/2024708 58 27 34 18 33 205 238 19 0 6 5 65
2024/20252.757 216 579 468 33 21 48 7 145 228 138 270 604
2025/20265.167 409 296 691 789 321 293 727 414 463 403 235 126
2026/2027499 105 308 86 0 0 0 0 0 0 0 0 0
Totale 17.707